118 related articles for article (PubMed ID: 8745740)
1. Clinical and serological observations on experimental infections with Babesia canis and its diagnosis using the IFAT.
Vercammen F; De Deken R; Maes L
Parasite; 1995 Dec; 2(4):407-10. PubMed ID: 8745740
[TBL] [Abstract][Full Text] [Related]
2. Humoral immunity and reinfection resistance in dogs experimentally inoculated with Babesia canis and either treated or untreated with imidocarb dipropionate.
Brandão LP; Hagiwara MK; Myiashiro SI
Vet Parasitol; 2003 Jun; 114(4):253-65. PubMed ID: 12809752
[TBL] [Abstract][Full Text] [Related]
3. Sterilisation of Babesia canis infections by imidocarb alone or in combination with diminazene.
Penzhorn BL; Lewis BD; de Waal DT; López Rebollar LM
J S Afr Vet Assoc; 1995 Sep; 66(3):157-9. PubMed ID: 8596187
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic and prophylactic efficacy of imidocarb dipropionate on experimental Babesia ovis infection of lambs.
Sevinc F; Turgut K; Sevinc M; Ekici OD; Coskun A; Koc Y; Erol M; Ica A
Vet Parasitol; 2007 Oct; 149(1-2):65-71. PubMed ID: 17709209
[TBL] [Abstract][Full Text] [Related]
5. The clinical course of babesiosis in 76 dogs infected with protozoan parasites Babesia canis canis.
Adaszek Ł; Winiarczyk S; Skrzypczak M
Pol J Vet Sci; 2009; 12(1):81-7. PubMed ID: 19459444
[TBL] [Abstract][Full Text] [Related]
6. Development of a practical immunochromatographic test with recombinant P50 for the diagnosis of Babesia gibsoni infection in dogs.
Verdida RA; Xuan X; Fukumoto S; Huang X; Zhou J; Igarashi I; Claveria FG; Nagasawa H
Parasitology; 2005 Dec; 131(Pt 6):769-74. PubMed ID: 16336730
[TBL] [Abstract][Full Text] [Related]
7. Detection and molecular characterization of a novel large Babesia species in a dog.
Birkenheuer AJ; Neel J; Ruslander D; Levy MG; Breitschwerdt EB
Vet Parasitol; 2004 Oct; 124(3-4):151-60. PubMed ID: 15381295
[TBL] [Abstract][Full Text] [Related]
8. Changes in selected subpopulations of lymphocytes in dogs infected with Babesia canis treated with imidocarb.
Adaszek Ł; Jarosz Ł; Kalinowski M; Staniec M; Grądzki Z; Salmons B; Winiarczyk S
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2015; 43(2):94-100. PubMed ID: 25771779
[TBL] [Abstract][Full Text] [Related]
9. Comparison between a soluble antigen-based ELISA and IFAT in detecting antibodies against Babesia canis in dogs.
Furuta PI; Oliveira TM; Theixeira MC; Rocha AG; Machado RZ; Tinucci-Costa MG
Rev Bras Parasitol Vet; 2009; 18(3):41-5. PubMed ID: 19772774
[TBL] [Abstract][Full Text] [Related]
10. Molecular fluorescent approach to assessing intraerythrocytic hemoprotozoan Babesia canis infection in dogs.
Bicalho KA; Ribeiro MF; Martins-Filho OA
Vet Parasitol; 2004 Nov; 125(3-4):221-35. PubMed ID: 15482880
[TBL] [Abstract][Full Text] [Related]
11. Repeated high dose imidocarb dipropionate treatment did not eliminate Babesia caballi from naturally infected horses as determined by PCR-reverse line blot hybridization.
Butler CM; Nijhof AM; van der Kolk JH; de Haseth OB; Taoufik A; Jongejan F; Houwers DJ
Vet Parasitol; 2008 Feb; 151(2-4):320-2. PubMed ID: 18160222
[TBL] [Abstract][Full Text] [Related]
12. Detection of a large unnamed Babesia piroplasm originally identified in dogs in North Carolina in a dog with no history of travel to that state.
Holman PJ; Backlund BB; Wilcox AL; Stone R; Stricklin AL; Bardin KE
J Am Vet Med Assoc; 2009 Oct; 235(7):851-4. PubMed ID: 19793016
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the indirect fluorescent antibody test for diagnosis of Babesia gibsoni infections in dogs.
Yamane I; Thomford JW; Gardner IA; Dubey JP; Levy M; Conrad PA
Am J Vet Res; 1993 Oct; 54(10):1579-84. PubMed ID: 8250380
[TBL] [Abstract][Full Text] [Related]
14. Evidence of an acute phase response in dogs naturally infected with Babesia canis.
Matijatko V; Mrljak V; Kis I; Kucer N; Forsek J; Zivicnjak T; Romić Z; Simec Z; Ceron JJ
Vet Parasitol; 2007 Mar; 144(3-4):242-50. PubMed ID: 17116368
[TBL] [Abstract][Full Text] [Related]
15. Babesiosis in a foal.
Silvey RE
Vet Rec; 1996 Oct; 139(17):428. PubMed ID: 9036621
[No Abstract] [Full Text] [Related]
16. Prevalence of antibodies against Babesia canis in dogs in an endemic area.
Bobade PA; Oduye OO; Aghomo HO
Rev Elev Med Vet Pays Trop; 1989; 42(2):211-7. PubMed ID: 2626574
[TBL] [Abstract][Full Text] [Related]
17. [Asymptomatic carriers of Babesia canis in an enzootic area].
Wlosniewski A; Leriche MA; Chavigny C; Ulmer P; Donnay V; Boulouis HJ; Mahl P; Druilhe P
Comp Immunol Microbiol Infect Dis; 1997 Jan; 20(1):75-86. PubMed ID: 9132337
[TBL] [Abstract][Full Text] [Related]
18. Canine babesiosis caused by Babesia canis vogeli in rural areas of the State of Minas Gerais, Brazil and factors associated with its seroprevalence.
Costa-Júnior LM; Ribeiro MF; Rembeck K; Rabelo EM; Zahler-Rinder M; Hirzmann J; Pfister K; Passos LM
Res Vet Sci; 2009 Apr; 86(2):257-60. PubMed ID: 18723199
[TBL] [Abstract][Full Text] [Related]
19. Babesia gibsoni: detection during experimental infections and after combined atovaquone and azithromycin therapy.
Jefferies R; Ryan UM; Jardine J; Robertson ID; Irwin PJ
Exp Parasitol; 2007 Oct; 117(2):115-23. PubMed ID: 17543304
[TBL] [Abstract][Full Text] [Related]
20. Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate.
Pasa S; Toz SO; Voyvoda H; Ozbel Y
Vet Parasitol; 2005 Mar; 128(3-4):243-9. PubMed ID: 15740861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
